Conclusion
AF
Despite the lack of any significant differences in resource use or costs among CDS and usual care groups in the IMPACT-AF trial, this study provides unique insight into the economic burden of AF among patients treated in the primary care setting. While much of the AF literature reports on the management of AF by cardiologists or other specialists [